Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M21,889Revenue (TTM) $M9,749Net Margin (%)8.3Altman Z-Score2.1
Enterprise Value $M28,166EPS (TTM) $1.6Operating Margin %14.4Piotroski F-Score5
P/E(ttm)27.6Beneish M-Score-2.5Pre-tax Margin (%)9.0Higher ROA y-yN
Price/Book2.110-y EBITDA Growth Rate %12.4Quick Ratio1.1Cash flow > EarningsY
Price/Sales2.25-y EBITDA Growth Rate %8.2Current Ratio1.7Lower Leverage y-yY
Price/Free Cash Flow15.0y-y EBITDA Growth Rate %2.7ROA % (ttm)3.6Higher Current Ratio y-yY
Dividend Yield %--PEG3.4ROE % (ttm)8.3Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M508ROIC % (ttm)7.7Gross Margin Increase y-yN

Gurus Latest Trades with MYL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
MYLDavid Tepper 2016-03-31 Sold Out -0.92%$41.42 - $54.09
($48.28)
$ 42.86-11%Sold Out0
MYLJoel Greenblatt 2016-03-31 Add0.44%$41.42 - $54.09
($48.28)
$ 42.86-11%Add 9178.19%837,728
MYLVanguard Health Care Fund 2016-03-31 Add0.25%$41.42 - $54.09
($48.28)
$ 42.86-11%Add 10.00%26,679,385
MYLJohn Paulson 2016-03-31 Add0.19%$41.42 - $54.09
($48.28)
$ 42.86-11%Add 2.38%23,335,861
MYLJohn Keeley 2016-03-31 Sold Out -0.09%$41.42 - $54.09
($48.28)
$ 42.86-11%Sold Out0
MYLMario Gabelli 2016-03-31 Reduce$41.42 - $54.09
($48.28)
$ 42.86-11%Reduce -35.73%17,000
MYLDavid Einhorn 2015-12-31 Buy 2.86%$39.16 - $55.28
($48.35)
$ 42.86-11%New holding2,890,000
MYLDavid Tepper 2015-12-31 Add0.41%$39.16 - $55.28
($48.35)
$ 42.86-11%Add 81.62%853,749
MYLJohn Paulson 2015-12-31 Add0.29%$39.16 - $55.28
($48.35)
$ 42.86-11%Add 4.02%22,794,061
MYLVanguard Health Care Fund 2015-12-31 Add0.11%$39.16 - $55.28
($48.35)
$ 42.86-11%Add 4.26%24,253,075
MYLMario Gabelli 2015-12-31 Reduce-0.01%$39.16 - $55.28
($48.35)
$ 42.86-11%Reduce -60.67%26,450
MYLJoel Greenblatt 2015-12-31 Buy 0.01%$39.16 - $55.28
($48.35)
$ 42.86-11%New holding9,029
MYLJohn Keeley 2015-12-31 Reduce$39.16 - $55.28
($48.35)
$ 42.86-11%Reduce -8.09%51,580
MYLDavid Tepper 2015-09-30 Reduce-0.87%$39.8 - $71.49
($55.75)
$ 42.86-23%Reduce -52.50%470,071
MYLVanguard Health Care Fund 2015-09-30 Add0.64%$39.8 - $71.49
($55.75)
$ 42.86-23%Add 46.38%23,262,875
MYLJohn Keeley 2015-09-30 Add0.02%$39.8 - $71.49
($55.75)
$ 42.86-23%Add 51.47%56,120
MYLMario Gabelli 2015-09-30 Add0.01%$39.8 - $71.49
($55.75)
$ 42.86-23%Add 102.26%67,250
MYLJohn Paulson 2015-06-30 Add2.24%$57.94 - $76.06
($70.49)
$ 42.86-39%Add 46.59%21,913,061
MYLDavid Tepper 2015-06-30 Buy 1.66%$57.94 - $76.06
($70.49)
$ 42.86-39%New holding989,528
MYLFirst Eagle Investment 2015-06-30 Sold Out -0.08%$57.94 - $76.06
($70.29)
$ 42.86-39%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

MYL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


MYL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MAROON JOSEPH C MDDirector 2016-05-25Buy2,370$42.470.92view
Cindrich Robert JDirector 2016-05-25Buy1,190$42.470.92view
HIGGINS MELINA EDirector 2016-05-12Buy19,900$38.6810.81view
HIGGINS MELINA EDirector 2016-05-06Buy100$38.6910.78view
HIGGINS MELINA EDirector 2016-04-28Buy35,000$42.92-0.14view
COURY ROBERT JExecutive Chairman 2016-04-05Sell217,755$45.96-6.74view
MAROON JOSEPH C MDDirector 2016-03-31Buy4,337$46.36-7.55view
PARRISH MARK WDirector 2016-03-17Buy1,705$44-2.59view
CAMERON WENDYDirector 2016-03-08Buy2,190$45.69-6.19view
Cindrich Robert JDirector 2016-03-03Buy2,187$45.83-6.48view

Press Releases about MYL :

Quarterly/Annual Reports about MYL:

News about MYL:

Articles On GuruFocus.com
Samuel Isaly Trades in Health Care Stocks in 1st Quarter Apr 27 2016 
John Keeley Comments on Mylan Labs Apr 26 2016 
Ackman to Testify About Valeant Before Senate Apr 26 2016 
Mawer's Investment Newsletter 1st Quarter Apr 15 2016 
Insiders Keep on Selling Facebook and Ford Apr 08 2016 
Buy Perrigo After a Big Selloff? Yes Apr 04 2016 
David Einhorn's Top 5 New Q4 Buys Feb 16 2016 
David Einhorn Rebounds – Somewhat Feb 09 2016 
Keeley Funds Comments on Mylan N.V. Feb 03 2016 
KEELEY All Cap Value Fund Commentary - 4th Quarter 2015 Feb 03 2016 

More From Other Websites
Mylan to Present at Goldman Sachs 37th Annual Global Healthcare Conference May 26 2016
5 Health Care Stocks Whose Charts Tell You to Wait to Buy May 26 2016
Lawsuit filed against former Mylan acquisition target Perrigo May 24 2016
5 Health Care Stocks John Paulson Is Betting On in 2016 May 24 2016
Stock Futures Edge Lower; Apple Reportedly Sets Strong IPhone Output May 23 2016
Hot New Solution For Diabetics May 23 2016
Mylan Launches First Generic Doryx® Delayed-Release Tablets, 200 mg May 23 2016
J&J is Worth as Much as Gilead, Biogen, Mylan, Celgene and Teva Combined. It's Time to Sell. May 20 2016
Mylan Updates Timetable for Commencement of Acceptance Period for Offer for Meda May 17 2016
Term Sheet — Monday, May 16 May 16 2016
Mylan to Buy Renaissance's Topical Business for about $1B May 16 2016
David Tepper's Q1 Moves: Apple, Valeant And Much More May 13 2016
Mylan Tacks On Another Generics Company on the Cheap May 13 2016
Mylan To Buy Renaissance Acquisition Holdings' Generic And Specialty Business For $950 Million May 13 2016
Mylan to Buy Renaissance Skin Drug Unit for About $1 Billion May 13 2016
Mylan to Acquire Renaissance's Leading Topicals-Focused Specialty and Generics Business May 13 2016
Top Analyst Upgrades and Downgrades: Allergan, Lockheed Martin, Mylan, Nordstrom, Petrobras, NVIDIA,... May 13 2016
Stocks: Healthcare's More Than Just Biotech May 12 2016
Mylan Launches Generic Frova® Tablets May 12 2016
Allergan Plans $10B Share Repurchase: Is the Stock a Buy? May 10 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)